Sleep disturbance in schizophrenia

References

• Abi-Dargham, A. (2004). Do we still believe in the dopamine hypothesis? New data bring new evidence. International Journal of Neuropsychopharmacology, 7 (Suppl. 1), S1–S5.
   Google Scholar
• Abi-Dargham, A., Gil, R, Krystal, J., Baldwin, R. M., Seibyl, J. P., & Bowers, M. (1998). Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort. American Journal of Psychiatry, 155, 761–767.
   Google Scholar
• American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th Edn, DSM-IV). Washington, DC: American Psychiatric Press.
   Google Scholar
• American Sleep Disorders Association (1997). International classification of sleep disorders, revised (ICSD-R). Diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association.
   Google Scholar
• Benca, M. R., Obermeyer, W. H., Thisted, R. A., & Gillin, C. J. (1992). Sleep and psychiatric disorders: A meta-analysis. Archives of General Psychiatry, 49, 651–668.
   PubMed Web of Science ®Google Scholar
• Benson, K. L., & Zarcone, V. P. (1993). Rapid eye movement sleep eye movements in schizophrenia and depression. Archives of General Psychiatry, 5, 474–482.
   Google Scholar
• Benson, K. L., Faull, K. F., & Zarcone, V. P. (1991). Evidence for the role of serotonin in the regulation of slow wave sleep in schizophrenia. Sleep, 14, 133–139.
   PubMed Web of Science ®Google Scholar
• Benson, K. L., Sullivan, E. V., Lim, K. 0., Lauriello, J., Zarcone, V.-P., 8z Pfefferbaum, A. (1996). Slow wave sleep and computed tomographic measures of brain morphology in schizophrenia. Psychiatry Research, 60, 125–134.
   Google Scholar
• Breier, A., Su, T. P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., et al. (1997). Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine con-centrations: Evidence from a novel positron emission tomo-graphy method. Proceedings of the National Academy of Sciences USA, 94, 2569–2574.
   PubMed Web of Science ®Google Scholar
• Caldwell, D. F., & Domino, D. F. (1967). Electroencephalographic and eye movement patterns during sleep in chronic schizophrenic patients. Electroencephalography and Clinical Neurophysiology, 22, 414–420.
   Google Scholar
• Carlsson, A., & Lindquist, M. (1963). Effects of chlorpromazine or haloperidol on formation of 3-methoxytyramine and norme-tanephrine in mouse brain. Acta Pharmacologica Toxicologica, 20, 140–144.
   PubMedGoogle Scholar
• Carlsson, A., Waters, N., Holm-Waters, S., Tedraff, S., Nilsson, M., & Carlsson, M. L. (2001). Interactions between mono-amines, glutamate, and GABA in schizophrenia: New evidence. Annual Review of Pharmacology and Toxicology, 4, 237–260.
   Google Scholar
• Carskadon, M. A., & Dement, W. C. (2000). Normal human sleep: An overview. In: M. H. Kryger, T. Roth & W. C. Dement (Eds), Principles and practice of sleep medicine (pp. 15–25). Philadelphia: WB Saunders Company.
   Google Scholar
• Feinberg, I., Braun, M., Koresko, R. L., & Gottlieb, F. (1969). Stage 4 sleep in schizophrenia. Archives of General Psychiatry, 21, 263–266.
   Google Scholar
• Ganguli, R., Reynolds, C. F., & Kupfer, D. J. (1987). Electroencephalographic sleep in young, never-medicated schizophrenics. Archives of General Psychiatry, 44,36–44.
   PubMed Web of Science ®Google Scholar
• Hiatt, J. F., Floyd, T. C., Katz, P. H., & Feinberg, I. (1985). Further evidence of abnormal non-rapid-eye-movements sleep in schizophrenia. Archives of General Psychiatry, 42, 797–802.
   Google Scholar
• Hobson, J. A., Stickgold, R., & Pace-Schott, E. F. (1998). The neuropsychology of REM sleep dreaming. NeuroReport, 9, R1–R14.
   Google Scholar
• Hoffmann, R, Hendricks, E. W., Rush, A. J., & Armitage, R. (2000). Slow-wave activity during non-REM sleep in men with schizophrenia and major depressive disorders. Psychiatry Research, 95, 215–225.
   Google Scholar
• Hudson, J. I., Lipinski, J. F., Keck, P. E., Aizley, H. G., Vuchovic, A., Zierch, K. C., et al. (1993). Polysomnographic characteristics of schizophrenia in comparison with mania and depression. Biological Psychiatry, 34,191–193.
   Google Scholar
• Janowsky, D. S., Davis, J. M., El-Yousef, M. K., & Sekerhe, H. J. (1972). A cholinergic-adrenergic hypothesis of mania and depression. Lancet, 2, 632–635.
   Google Scholar
• Jus, K., Bouchard, M., Jus, A. K., Villenuve, A., & Lachance, R. (1973). Sleep EEG studies in untreated, long-term schizo-phrenic patients. Archives of General Psychiatry, 29, 386–390.
   PubMed Web of Science ®Google Scholar
• Kempenaers, C., Kerkhofs, M., Linkowski, P., & Mendlewicz, J. (1988). Sleep EEG variables in young schizophrenic and depressive patients. Biological Psychiatry, 24, 833–838.
   Google Scholar
• Keshavan, M. S., Reynolds, C. F., & Kupfer, D. J. (1990). Electroencephalographic sleep in schizophrenia: A critical review. Comprehensive Psychiatry, 31, 34–47.
   Google Scholar
• Laruelle, M., Abi-Dargham, A., Van Dyck, C. H., Gil, R., D'Souza, C. D., Eidos, J., et al. (1996). Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proceedings of the National Academy of Sciences of the United States of America, 93, 9235–9240.
   Google Scholar
• Lauer, C. J., & Krieg, J. C. (1998). Slow-wave sleep and ventricular size: A comparative study in schizophrenia and major depression. Biological Psychiatry, 44, 121–128.
   PubMed Web of Science ®Google Scholar
• Lauer, C. J., Schreiber, W., Pollmächer, T., Holsboer, F., & Krieg, J. C. (1997). Sleep in schizophrenia: A polysomnographic study of drug-naive patients. Neuropsychophannacology, 16, 51–60.
   Google Scholar
• McCrae, C. S., & Lichstein, K. L. (2001). Secondary insomnia: Diagnostic challenges and intervention opportunities. Sleep Medicine Reviews, 5, 47–61.
   PubMed Web of Science ®Google Scholar
• Monti, J. M. (2004a). Primary and secondary insomnia: Prevalence, causes and current therapeutics. Current Medicinal Chemistry-G'NS Agents, 4, 119–137.
   Google Scholar
• Monti, J. M. (2004b). Pharmacological treatment of insomnia: The non-benzodiazepine receptor agonists. International Journal of Neuropsychophannacology, 7 (Suppl. 1), S90.
   Google Scholar
• Monti, J. M., & Monti, D. (2000). Sleep disturbance in general-ized anxiety disorder and its treatment. Sleep Medicine Reviews, 4,263–276.
   PubMed Web of Science ®Google Scholar
• Monti, J. M., & Monti, D. (2004). Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Medicine Reviews, 8, 133–148.
   PubMed Web of Science ®Google Scholar
• Monti, J. M., Hawkins, M., Jantos, H., D'Angelo, L., & Fernandez, R (1988). Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychophannacology, 95, 395–400.
   Google Scholar
• Monti, J. M., Jantos, H., & Fern6ndez, M. (1989). Effects of the dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat. European Journal of Pharmacology, 169, 61–66.
   Google Scholar
• Poulin, J., Daoust, A.-M., Forest, G., Stip, E., & Godbout, R. (2003). Sleep architecture and its clinical correlates in first episode and neuroleptic-naive patients with schizophrenia. Schizophrenia Research, 62, 147–163.
   Google Scholar
• Rechtschaffen, A., & Kales, A. (1968). A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Government Printing Office. Washington, DC, Washington Printing Office.
   Google Scholar
• Ritsner, M., Kurs, R., Ponizovsky, A., & Hadjez, J. (2004). Perceived quality of life in schizophrenia: Relationship to sleep quality. Quality of Life Research, 13, 783–791.
   PubMed Web of Science ®Google Scholar
• Stern, M., Fram, D. H., Wyatt, R., Grinspoon, L., & Tulshy, B. (1969). All-night sleep studies of acute schizophrenics. Archives of General Psychiatry, 20, 470–477.
   PubMed Web of Science ®Google Scholar
• Taheri, S., Zeitzer, J. M., & Mignot, E. (2002). The role of hypocretins (orexins) in sleep regulation and narcolepsy. Annual Review of Neuroscience, 25, 283–313.
   PubMed Web of Science ®Google Scholar
• Tandon, R., Shipley, J. E., Taylor, S., Greden, J. F., Eiser, A., DeAnardo, J., et al. (1992). Electroencephalographic sleep abnormalities in schizophrenia. Archives of General Psychiatry, 49, 185–194.
   Google Scholar
• Van Kammen, D. P., Van Kammen, W. B., Peters, J. L., Rosen, J., Slawsky, R.C., Neylan, T., et al. (1986). CSF MHPG, sleep and psychosis in schizophrenia. Clinical Neurophannacology, 9 (Suppl. 4), 575–577.
   Google Scholar
• Wassef, A. A., Dott, S. G., Harris, A., Brown, A., O'Boyle, M., Meyer, W. J., et al. (1999). Critical review of GABA-ergic drugs in the treatment of schizophrenia. Journal of Clinical Psychophannacology, 19, 222–232.
   Google Scholar
• Wassef, A., Baker, J., & Kochan, L. D. (2003). GABA and schizophrenia: A review of basic science and clinical studies. Journal of Clinical Psychophannacology, 23, 601–640.
   PubMed Web of Science ®Google Scholar
• Williams, R. L., Karacan, I., & Moore, C. A. (1988). Introduction. In: R. L. Williams, I. Karacan & C. A. Moore (Eds), Sleep disorders-Diagnosis and treatment (pp. 3–7). New York: John Wiley & Sons.
   Google Scholar
• Zarcone, V. P., Benson, K. L., 8z Berger, P. A. (1987). Abnormal rapid eye movement latencies in schizophrenia. Archives of General Psychiatry, 44, 45–48.
   Google Scholar